Neuroproteomics and Parkinson’s disease: don’t forget human samples

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

(2011)   LANCET

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

Advances in environmental epidemiology

(2010) Caroline M. Tanner   MOVEMENT DISORDERS

Parkinson's disease: a model dilemma

(2010) M. Flint Beal   NATURE

Proteomics in human Parkinson's disease research

(2009) Virginie Licker et al.   Journal of Proteomics

Parkinson's disease

(2009) Andrew J Lees et al.   LANCET

Biological fluid biomarkers in neurodegenerative parkinsonism

(2009) Michael Eller et al.   Nature Reviews Neurology

CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases

(2008) Jing Zhang et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Non-motor symptoms in Parkinson’s disease

(2008) W. Poewe   EUROPEAN JOURNAL OF NEUROLOGY

Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

(2008) Brit Mollenhauer et al.   EXPERIMENTAL NEUROLOGY

Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease

(2008) Carola Schiesling et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Assessing quantitative post-mortem changes in the gray matter of the human frontal cortex proteome by 2-D DIGE

(2008) Anna Crecelius et al.   PROTEOMICS